Molina Healthcare (MOH) director receives quarterly $55,000 equity stock grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Schapiro Richard M reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Richard M. Schapiro received a stock grant as part of his board compensation. He was awarded 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan, valued at $55,000 based on the closing price of $232.55 per share.

The filing explains this is one quarter of an annual equity award of $220,000 to each director, granted in four equal quarterly installments. Following this award, Schapiro directly holds 12,311 shares of Molina Healthcare common stock, reflecting ongoing, routine equity-based compensation for his service as a director.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schapiro Richard M

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	237	$232.55	$55K

Holdings After Transaction: Common Stock — 12,311 shares (Direct, null)

Footnotes (1)

Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares. Represents the closing price of the Issuer's common stock on July 1, 2026.

Key Figures

Shares granted: 237 shares Grant valuation: $55,000 Annual equity award: $220,000 +2 more

5 metrics

Shares granted 237 shares Quarterly director equity grant on July 1, 2026

Grant valuation $55,000 Quarterly portion of director annual equity award

Annual equity award $220,000 Total annual equity compensation per director

Grant price per share $232.55/share Closing price of common stock on July 1, 2026

Shares owned after grant 12,311 shares Director’s direct holdings following the transaction

Key Terms

2025 Equity Incentive Plan, annual equity award, Common Stock

3 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection..."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set..."

Common Stock financial

"Represents the closing price of the Issuer's common stock on July 1, 2026."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:53 PM Accepted by SEC EDGAR 07/02/2026 - 04:52 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schapiro Richard M

(Last)

(First)

(Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH

CALIFORNIA

90802

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/01/2026		A⁽¹⁾		237⁽²⁾	A	$232.55⁽³⁾	12,311	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2026.

Remarks:

	Jeff D. Barlow, by power of attorney for Richard M. Schapiro.	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Molina Healthcare (MOH) director Richard Schapiro receive in this Form 4 filing?

Richard Schapiro received a grant of 237 shares of Molina Healthcare common stock on July 1, 2026. The grant was issued under the 2025 Equity Incentive Plan as part of his routine director compensation for serving on the company’s board.

What is the dollar value of the Molina Healthcare (MOH) stock grant to Richard Schapiro?

The stock grant to Richard Schapiro is valued at $55,000 based on 237 shares at a closing price of $232.55 on July 1, 2026. This amount represents one quarterly installment of his annual equity award.

How is the annual equity award structured for Molina Healthcare (MOH) directors?

Each Molina Healthcare director receives an annual equity award of $220,000 in company stock. This is split into four equal quarterly grants of $55,000 each, determined using the closing price of Molina Healthcare common stock on the first day of each quarter.

How many Molina Healthcare (MOH) shares does Richard Schapiro hold after this transaction?

After receiving the 237-share grant, Richard Schapiro directly holds 12,311 shares of Molina Healthcare common stock. This total reflects his updated ownership position following the July 1, 2026 equity award reported in the Form 4 filing.

At what price was the Molina Healthcare (MOH) stock grant to Richard Schapiro calculated?

The grant was calculated using the closing price of Molina Healthcare common stock on July 1, 2026, which was $232.55 per share. This price was used to determine how many shares equaled the $55,000 quarterly equity award.